Medische Oncologie

Sandrine Aspeslagh
- UZBrussel
- Vrije Universiteit Brussel
- Interne Geneeskunde - UZB Physician
- https://lmmo.research.vub.be/en/home
- Observerende Klinische wetenschappen - Academisch personeel
- Medische Oncologie - UZB Physician
Persoon: Onderzoeker, Physician, Professor
20112023
Gil Awada
- UZBrussel
- Vrije Universiteit Brussel
- Medische Oncologie - UZB Physician
- https://lmmo.research.vub.be/en/home
Persoon: Onderzoeker, Physician
20152023
Lore Decoster
- UZBrussel
- Vrije Universiteit Brussel
- Observerende Klinische wetenschappen - Academisch personeel
- Medische Oncologie - UZB Physician
- https://lmmo.research.vub.be/en/home
Persoon: Onderzoeker, Professor, Physician
20042023
Amy De Haar-Holleman
- UZBrussel
- Vrije Universiteit Brussel
- https://lmmo.research.vub.be/en/home
- Medische Oncologie - UZB Physician
Persoon: Onderzoeker, Physician
Iris Dirven
- UZBrussel
- Vrije Universiteit Brussel
- https://lmmo.research.vub.be/en/home
- Observerende Klinische wetenschappen - Academisch personeel, Doctoral scholarschip
- Medische Oncologie - UZB Physician
- Faculteit van de Geneeskunde en Farmacie
Persoon: Onderzoeker, Physician, Doctoraat, Master-na-Master
20222023

2 Afgelopen
2 Actief

AIIFUND73: Ongelijkheden bij het levenseinde bij kanker en dementie: een studie met gemengde methoden
Van den Block, L., Gilissen, J. & Decoster, L.
1/06/21 → 30/06/23
Project: Fundamenteel
FWOTBM3: Een gerandomiseerde fase II klinische studie in NSCLC van SBRT en I.V. anti-PD-1 met of zonder I.T. anti-CTLA-4/anti-PD-L1 plus CD1c+ myDC
Neyns, B.
1/10/19 → 30/09/23
Project: Toegepast
IWTOO24: Baekelandmandaat: Preklinische ontwikkeling van een mRNA kankervaccin voor intraveneuze administratie
Thielemans, K. & Bevers, S.
1/02/18 → 31/01/22
Project: Toegepast
IWTOO25: Baekelandmandaat: In situ mRNA vaccinatie: het gevecht naar de tumor brengen
Breckpot, K., Thielemans, K. & Locy, H.
1/01/18 → 30/11/22
Project: Toegepast

A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients.
Gondry, O., Xavier, C., Heemskerk, J., Raes, L. A. J., Debacker, J., De Geeter, F., Fontaine, C., Vanhoeij, M., Aspeslagh, S., Joris, S., De Grève, J., Verfaillie, G., Luyten, I., De Mey, L., Vandenbroucke, F., Waelput, W., Glorieus, K., Bourgeois, S., Cousaert, J., Vaneycken, I. & 5 anderen, Devoogdt, N., Everaert, H., Caveliers, V., Lahoutte, T. & Keyaerts, M., 2023.
Onderzoeksoutput: Unpublished abstract
Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study
Fasolino, G., Awada, G., Moschetta, L., Koulalis, J. S., Neyns, B., Verhelst, B., Van Elderen, P., Nelis, P., de Lichtbuer, P. C., Cools, W. & Ten Tusscher, M., 3 feb 2023, In: Journal of clinical medicine. 12, 3, 1214.
Onderzoeksoutput: Article › peer review

Open Access
Auto-immune hemolytic anemia and hemophagocytic lymphohistiocytosis as immune-related adverse event in patients with metastatic melanoma and concurrent chronic lymphocytic leukemia: a case series and literature review
Dirven, I., Vander Mijnsbrugge, A-S., Mignon, S., Tijtgat, J., Kint, N. & Neyns, B., 28 apr 2023, In: Melanoma Research.
Onderzoeksoutput: Article › peer review
Current "state of the art" on dendritic cell-based cancer vaccines in melanoma
Schwarze, J. K., Geeraerts, X., Tuyaerts, S. & Neyns, B., 1 mrt 2023, In: Current Opinion in Oncology. 35, 2, blz. 87-93 7 blz.
Onderzoeksoutput: Article › peer review

Open Access

3 Citaten (Scopus)
Features of post-obstructive pneumonia in advanced lung cancer patients, a large retrospective cohort
Moretti, M., Wellekens, S., Dirkx, S., Vekens, K., Van Laethem, J., Ilsen, B. & Vanderhelst, E., feb 2023, In: Infectious diseases (London, England). 55, 2, blz. 149-157 9 blz.
Onderzoeksoutput: Article › peer review

35 Talk or presentation at a conference
11 Talk or presentation at a workshop/seminar
9 Participation in conference
8 Participation in workshop, seminar
Meer

2023 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship
Marthe Verhaert (Participant)
14 apr 2023
Activiteit: Written proposal
Kom Op Tegen Kanker projectaanvraag
Marthe Verhaert (Participant)
14 feb 2023
Activiteit: Written proposal
Investigating the clinical application and in vitro effect of regorafenib in advanced and metastatic melanoma and overcoming acquired resistance to targeted therapies.
Iris Dirven (Participant)
27 feb 2023
Activiteit: Written proposal

Bestand
FWO PhD fellowship strategic basic research
Marthe Verhaert (Participant)
28 feb 2023
Activiteit: Written proposal
2023 SITC-Merck Cancer Immunotherapy Clinical Fellowship
Marthe Verhaert (Participant)
14 apr 2023
Activiteit: Written proposal

Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls
Neyns, B. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.12952161
Dataset
Additional file 6: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
Van Dooren, S. (Creator), Teugels, E. (Creator), Bonduelle, M. (Creator), Shahi, R. B. (Creator), De Brakeleer, S. (Creator), Vanhoeij, M. (Creator), Joris, S. (Creator), Fontaine, C. (Creator), Pauwels, I. (Creator), Caljon, B. (Creator) & De Grève, J. (Creator), Springer, 2019
DOI: 10.6084/m9.figshare.7956710, http://10.1186/s12885-019-5494-7
Dataset

Medische Oncologie

Vingerafdruk

Netwerk

Duik in details

Sandrine Aspeslagh

Gil Awada

Lore Decoster

Amy De Haar-Holleman

Iris Dirven

AIIFUND73: Ongelijkheden bij het levenseinde bij kanker en dementie: een studie met gemengde methoden

FWOTBM3: Een gerandomiseerde fase II klinische studie in NSCLC van SBRT en I.V. anti-PD-1 met of zonder I.T. anti-CTLA-4/anti-PD-L1 plus CD1c+ myDC

IWTOO24: Baekelandmandaat: Preklinische ontwikkeling van een mRNA kankervaccin voor intraveneuze administratie

IWTOO25: Baekelandmandaat: In situ mRNA vaccinatie: het gevecht naar de tumor brengen

A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients.

Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study

Auto-immune hemolytic anemia and hemophagocytic lymphohistiocytosis as immune-related adverse event in patients with metastatic melanoma and concurrent chronic lymphocytic leukemia: a case series and literature review

Current "state of the art" on dendritic cell-based cancer vaccines in melanoma

Features of post-obstructive pneumonia in advanced lung cancer patients, a large retrospective cohort

2023 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship

Kom Op Tegen Kanker projectaanvraag

Investigating the clinical application and in vitro effect of regorafenib in advanced and metastatic melanoma and overcoming acquired resistance to targeted therapies.

FWO PhD fellowship strategic basic research

2023 SITC-Merck Cancer Immunotherapy Clinical Fellowship

Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls

Additional file 6: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families

Medische Oncologie

Vingerafdruk

Netwerk

Profielen

projecten

Onderzoeksoutput

Activiteiten

Datasets